Anti-HTLV-I/II Seroprevalence in healthy blood donors in Izmir, Turkey

Turkish Journal of Haematology

Volumn 20, Issue 2, 2003, Pages 81-83

  Yazan Sertöz, Rüçhan ^a   Erensoy, Selda ^a   Özçam, Halime ^a   Altuǧlu, Imre ^a   Taşbakan, Meltem ^a   Töbü, Mahmut ^a   Bilgiç, Altinay ^a  

^a EGE UNIVERSITY   (Turkey)

Author keywords

Blood donor; HTLV

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; HUMAN T CELL LEUKEMIA VIRUS ANTIBODY;

ADULT; ARTICLE; BLOOD DONOR; ENZYME IMMUNOASSAY; FEMALE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 2; MALE; NORMAL HUMAN; SCREENING; SERODIAGNOSIS; SEROPREVALENCE; SERUM; TURKEY (REPUBLIC); UNIVERSITY HOSPITAL;

EID: 0038084277     PISSN: 13007777     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Centers for Disease Control and Prevention and the USPHS Working Group. Guidelines for counseling persons infected with human T-lymphotropic virus type I (HTLVI) and type II (HTLVII). Ann Intern Med 1993;118:448-54.
2. Henrard DR, Soriano V, Robertson, et al and the HTLV-1 and HTLV-2 Spanish Study Group. J Clin Microbiol 1995;33:1735-8.
3. Hjelle B, Appenzeller O, Mills R, et al. Chronic neurodegenerative disease associated with HTLV-II infection. Lancet 1992;339:645-6.
4. Zucker-Franklin D, Hooper WC, Evatt BL. Human lymphotropic retroviruses associated with mycosis fungoides: Evidence that T-cell lymphotropic virus type II (HTLV-II) as well as HTLV-I may play a role in the disease. Blood 1992;80:1537-45.
5. Loughran TP Jr, Coyle T, Sherman MP, Starkebaum G, Erlich GD, Ruscetti FW, Poiesz BJ. Detection of human T-cell leukemia/lymphoma virus type II, in a patient with large granular lymphocyte leukemia. Blood 1992;80:1116-9.
6. Höllsberg P, Hafler DA. Pathogenesis of diseases induced by human lymphotropic virus type I. N Engl J Med 1993;328:1173-82.
7. Varma M, Rudolph DL, Knuchel M, et al. Enhanced specificity of truncated transmembrane protein for serologic confirmation of human T cell virus type 1 (HTLV-1) and HTLV-2 infections by western blot (immunoblot) assay containing recombinant envelop glycoproteins. J Clin Mic 1995;33:3239-44.
8. Dezzutti CS, Lal RB. Human T cell lymphotropic virus type I and II. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Volken RH (eds). Manual of Clinical Microbiology. New York: ASM Press, 2000:871-7.
9. Hall WW, Ishak R, Zhu SW, et al. Human T lymphotropic virus type II (HTLV-II): Epidemiology and molecular properties and clinical features of infection. AIDS Res Hum Retroviruses 1996;13(Suppl 1):204-14.
10. Dube DK, Dube S, Erensoy S, et al. Serological and nucleic acid analyses for HIV and HTLV infection on archival human plasma samples from Zaire. Virology 1994;202:379-89.
11. Bush MP, Laycock M, Kleinman SH, et al and the retrovirus epidemiology donor study. Accuracy of supplementary serologic testing for human T lymphotropic virus I and II in US blood donors. Blood 1994;83:1143-48.
12. Yenen OS. Anti-HTLV-I seroprevalence in healthy blood donors and a group of patients with various diseases. Türk Mikrobiol Cem Derg 1988;18:47-58.
13. Yenen OS, Beyazyürek M, Keskin K, et al. Screening HBsAg, anti-HBC, anti-HCV, anti-HTLV-I, anti-HIV1/2 in intravenous drug users. Klimik Derg 1993;6:35-6.